DIAMOND BIOFUND INC
Diamond Biofund Inc. is a venture capital firm specializing in evergreen funds. The firm seeks investment in start-ups and early ventures. It typically invests in biotechnology and medical investments, including new drug R&D, high-end medical equipment, innovative medical services and channels, and agricultural biotechnology. Diamond Biofund Inc. was founded in 2013 and is based in Taipei, Taiwan.
DIAMOND BIOFUND INC (6901) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: -0.002x
Based on the latest financial reports, DIAMOND BIOFUND INC (6901) has a cash flow conversion efficiency ratio of -0.002x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$-20.80 Million) by net assets (NT$9.23 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
DIAMOND BIOFUND INC - Cash Flow Conversion Efficiency Trend (2019–2024)
This chart illustrates how DIAMOND BIOFUND INC's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
DIAMOND BIOFUND INC Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of DIAMOND BIOFUND INC ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Shanghai Broadband Technology Co Ltd
SHG:600608
|
0.572x |
|
Bonduelle S.C.A.
PA:BON
|
-0.240x |
|
Figeac Aero SA
PA:FGA
|
0.273x |
|
Hana Technology Co. Ltd
KQ:299030
|
0.031x |
|
Taiyen Biotech Co Ltd
TW:1737
|
0.028x |
|
Siamgas and Petrochemicals Public Company Limited
BK:SGP
|
0.126x |
|
AROAF
PINK:AROAF
|
N/A |
|
Namsun Alumini
KO:008350
|
-0.005x |
Annual Cash Flow Conversion Efficiency for DIAMOND BIOFUND INC (2019–2024)
The table below shows the annual cash flow conversion efficiency of DIAMOND BIOFUND INC from 2019 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | NT$10.37 Billion | NT$1.14 Billion | 0.110x | +821.33% |
| 2023-12-31 | NT$12.86 Billion | NT$-195.82 Million | -0.015x | -135.56% |
| 2022-12-31 | NT$11.05 Billion | NT$473.09 Million | 0.043x | +248.09% |
| 2021-12-31 | NT$10.39 Billion | NT$-300.42 Million | -0.029x | -260.45% |
| 2020-12-31 | NT$9.10 Billion | NT$-72.99 Million | -0.008x | +38.98% |
| 2019-12-31 | NT$3.01 Billion | NT$-39.57 Million | -0.013x | -- |